Trademark: 90272634
Status Date
Wednesday, March 6, 2024
Filing Date
Thursday, October 22, 2020
Published for Opposition
Tuesday, July 27, 2021
44 Providing medical information; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders
42 Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders
Mar 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2024
Sou Extension 5 Granted
Mar 6, 2024
Sou Extension 5 Filed
Mar 6, 2024
Sou Teas Extension Received
Sep 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2023
Sou Extension 4 Granted
Sep 19, 2023
Sou Extension 4 Filed
Sep 19, 2023
Sou Teas Extension Received
Feb 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2023
Sou Extension 3 Granted
Feb 21, 2023
Sou Extension 3 Filed
Feb 21, 2023
Sou Teas Extension Received
Sep 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2022
Sou Extension 2 Granted
Aug 30, 2022
Sou Extension 2 Filed
Aug 30, 2022
Sou Teas Extension Received
Mar 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2022
Sou Extension 1 Granted
Mar 21, 2022
Sou Extension 1 Filed
Mar 21, 2022
Sou Teas Extension Received
Sep 21, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 27, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 27, 2021
Published For Opposition
Jul 7, 2021
Notification Of Notice Of Publication E-Mailed
Jun 21, 2021
Approved For Pub - Principal Register
Jun 21, 2021
Examiner's Amendment Entered
Jun 21, 2021
Notification Of Examiners Amendment E-Mailed
Jun 21, 2021
Examiners Amendment E-Mailed
Jun 21, 2021
Examiners Amendment -Written
Jun 16, 2021
Teas/Email Correspondence Entered
Jun 16, 2021
Correspondence Received In Law Office
Jun 16, 2021
Teas Response To Office Action Received
Dec 17, 2020
Notification Of Non-Final Action E-Mailed
Dec 17, 2020
Non-Final Action E-Mailed
Dec 17, 2020
Non-Final Action Written
Dec 15, 2020
Assigned To Examiner
Dec 12, 2020
New Application Office Supplied Data Entered
Oct 26, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
